What is it about?
We compare the clinical studies performed using Restasis (0.05%) and Ikervis (0.1%) in dry eye disease.
Featured Image
Photo by Ridham Nagralawala on Unsplash
Why is it important?
Currently, there are only two common topical immunosuppressive eyedrops for use in dry eye.
Perspectives
Read the Original
This page is a summary of: A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease, Clinical Ophthalmology, June 2020, Taylor & Francis,
DOI: 10.2147/opth.s256351.
You can read the full text:
Contributors
The following have contributed to this page